Science

AddToAny

Google+ Facebook Twitter Twitter

Secondary malignancy: a case study

Healthcare Science Section Lead Michelle Bolam presents a case study in which a patient with chronic lymphocytic leukaemia was later diagnosed with chronic myeloid leukaemia.

Routine monitoring bloods were received into the laboratory from Haematology Outpatients on a 73-year-old female with a clinical history of a chronic lymphocytic leukaemia (CLL), diagnosis in 1999. The patient underwent chemotherapy for this in 2019 in the form of chorambucil and obinutuzumab to control the CLL, which was in remission.

When comparing the patient’s full blood count (FBC) on this occasion to their previous sample four months prior there was a marked difference (results shown in Table 1). The patient now appeared to have a leucocytosis and a thrombocytosis, which did not match with the patient’s clinical history of CLL. A peripheral blood film was made in order to investigate the many abnormal parameters to ensure the analyser was giving accurate results.

Click here to read the full article

Image credit | Shutterstock

Related Articles

web_blood-testing_credit_istock-1384651794.png

SPONSORED: The power of automated gel-based ID-cards in routine immunohematology workflows

Immuno-haematology assays are pivotal to the carrying out of blood grouping, antibody screening and transfusions, and represent a critically time-dependent stage in the patient management pathway.

Technician holding a blood sample ready for testing with other human medical samples in the background.-Image credit - Science-Photo-Library-f0243823

Machine learning tool to detect cancer via liquid biopsy

US researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.

multiple myelomatosis-CREDIT-Science Photo Library-m132099

IBMS research grants

We look at the work of Dr Mosavar Farahani who received an IBMS Research Grant in 2023 to help fund her work on disease progression and skeletal complications in multiple myeloma.

Jaxon Moran and Emily Jones

My Lab: Flow cytometry laboratory

Jaxon Moran and Emily Jones give a guided tour of the Flow Cytometry Laboratory at Newcastle upon Tyne Hospitals NHS Foundation Trust.

Top